He never achieved detectable ADAMTS13 activity level while receiving caplacizumab therapy; however, interestingly he exhibited significant improvement in hemolytic anemia, thrombocytopenia, and overall functional status. The gene discussed is ADAMTS13; the disease is Thrombocytopenia.